Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10517 in Chinese Adults with COVID-19
NCT05779579Phase 2Unknown
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Feb 2023
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HS-10517 in coronavirus disease 2019 (COVID-19), sponsored by Hansoh Pharmaceutical Group. Status: unknown.
02
Drugs
HS-10517
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05779579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05779579.